Stay updated on Efficacy of HZN-825 in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Efficacy of HZN-825 in Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the Efficacy of HZN-825 in Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check7 days agoChange DetectedThe page has updated its certification and extension dates, with the addition of new dates for 2025 and the removal of older dates from January and February 2025.SummaryDifference0.5%
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedThe page indicates that a trial has been terminated due to not meeting key endpoints, and it provides updated dates related to the trial's status. Additionally, there is a notice about heavy traffic affecting NLM-NCBI services.SummaryDifference2%
- Check43 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.0%
- Check57 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check64 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in its functionality.SummaryDifference0.1%
Stay in the know with updates to Efficacy of HZN-825 in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of HZN-825 in Idiopathic Pulmonary Fibrosis Clinical Trial page.